30 Pain Intensity Reduction Statistics from Evidence-Based Programs

‍Data from randomized controlled trials, systematic reviews, and national health surveys on behavioral, psychological, and multimodal approaches to chronic pain management

Chronic pain affects nearly one in four US adults, costing the economy hundreds of billions annually in healthcare spending and lost productivity. Yet the most commonly prescribed treatments, including opioids, injections, and surgery, frequently provide incomplete or temporary relief. Federal guidelines, major health systems, and a growing body of randomized trial evidence now support behavioral and psychological programs as effective options for reducing chronic pain. The 30 statistics below document this shift, drawing from peer-reviewed journals, Cochrane reviews, CDC surveillance data, and national health surveys to show what non-pharmacologic pain care can measurably achieve.

Key Takeaways

• An estimated 24.3% of US adults live with chronic pain, costing the economy $725 billion per year, yet most of those with chronic low back pain never receive evidence-based psychological treatment.
• Pain Reprocessing Therapy reduced chronic back pain to near-zero in 66% of participants, with 55% maintaining that relief at 5-year follow-up without booster sessions.
• Emotional Awareness and Expression Therapy outperformed CBT in head-to-head trials, producing pain reduction in 63% of older veterans with musculoskeletal pain compared to 17% receiving CBT.
• Exercise therapy reduces chronic low back pain by an average of 15 points per trial, supported by 249 randomized trials and 24,486 participants.
• Coach-led telehealth programs achieve clinically significant pain reduction at rates 54% above usual care, expanding access beyond geographic barriers.

The Chronic Pain Landscape: Scale and Urgency

1. 24.3% of US adults report chronic pain, affecting more than 60 million people

The most recent nationally representative survey data confirms that one in four adults lives with pain lasting three months or longer. Published in NCHS Data Brief No. 518 (November 2024) and based on the 2023 National Health Interview Survey, this figure reflects a slight increase from the 20.9% reported in earlier surveillance cycles. Chronic pain remains more prevalent than diabetes, depression, and heart disease individually.

2. 8.5% of US adults experience high-impact chronic pain that frequently limits daily life

Within the broader chronic pain population, roughly 22 million adults affected by high-impact chronic pain regularly face interference with work, social activities, or self-care. This distinction matters clinically because high-impact chronic pain carries disproportionate healthcare costs and disability burden. These individuals are often cycling through medications and procedures without sustained improvement.

3. Chronic pain costs the US economy an estimated $725 billion annually

A 2024 analysis of US claims data placed the all-cause economic burden of chronic pain at $725 billion per year. That figure includes direct healthcare costs averaging $23,705 per patient annually, plus indirect costs from missed work and reduced productivity. Chronic pain's economic footprint exceeds the combined costs of heart disease, cancer, and diabetes.

4. Women experience chronic pain at higher rates than men, at 25.4% vs 23.2%

National survey data shows a gender disparity in prevalence, with women reporting both higher overall rates and higher rates of high-impact chronic pain. This gap likely reflects biological, psychosocial, and healthcare-access factors. Evidence-based programs that address the emotional and cognitive dimensions of pain may be particularly relevant for populations facing compounding risk factors.

5. Most adults with chronic low back pain never receive evidence-based psychological therapy

Despite clinical guideline recommendations, psychological treatment remains limited for adults with chronic pain. Workforce shortages among pain-trained psychologists, limited insurance coverage, and geographic barriers all contribute to this gap. The mismatch between what guidelines recommend and what patients actually receive represents one of the largest unmet needs in pain medicine.

{{cta_2}}

The Comorbidity Crisis: Why Integrated Programs Matter

6. 39.3% of chronic pain patients have comorbid depression and 40.2% have anxiety

A 2025 global meta-analysis spanning 376 studies, 50 countries and 347,468 individuals quantified the scale of mental health comorbidity in chronic pain. Programs that treat pain in isolation, without addressing co-occurring depression and anxiety, miss a critical driver of pain persistence. Integrated behavioral approaches that target both conditions simultaneously show improved outcomes for each.

7. Opioid-treated chronic pain patients incur more than double the healthcare costs of those not receiving opioids

A 2024 analysis of US claims data found that costs more than double for chronic pain patients treated with opioids compared to those who did not receive opioids. This cost disparity, combined with limited evidence for long-term opioid efficacy in chronic non-cancer pain, strengthens the case for non-pharmacologic programs as both clinically and economically sound alternatives.

8. The CDC's 2022 guideline recommends non-pharmacologic therapies as preferred first-line for chronic pain

The CDC opioid prescribing guideline, published in MMWR 2022, formally recommends maximizing nonpharmacologic and nonopioid pharmacologic therapies before considering opioids for subacute and chronic pain. This recommendation, grounded in AHRQ systematic reviews, marks a federal-level endorsement of the behavioral and physical approaches documented throughout this article.

Cognitive Behavioral Therapy: The Most-Studied Foundation

9. Psychological therapies demonstrate consistent benefits for chronic pain across 75 randomized trials and 9,401 participants

The most comprehensive synthesis of psychological therapies for chronic pain, a Cochrane systematic review, found small-to-moderate improvements in pain, disability, and psychological distress at both post-treatment and follow-up. CBT was evaluated in 59 of those 75 trials, making it the most-studied modality. Quality of evidence was rated moderate for most outcomes, providing a strong foundation for clinical recommendations.

10. A 2025 meta-analysis of high-quality RCTs found CBT reduces musculoskeletal pain intensity with SMD = -0.41

Restricting analysis to 14 high-quality trials (2,677 participants with musculoskeletal pain), CBT's pain-reduction effect remained statistically and clinically meaningful. This confirms that CBT's benefits are not artifacts of lower-quality study designs. The effect size of -0.41 represents a meaningful clinical difference for adults living with persistent pain.

11. Approximately 61% of participants receiving MBSR achieved clinically meaningful functional improvement vs 44% with usual care

A 342-patient randomized trial compared 8-week group MBSR, group CBT, and usual care for chronic low back pain. Both active treatments significantly outperformed usual care for functional limitations at 26 weeks, and benefits persisted at one year. Pain bothersomeness improved in 44% of the mindfulness group and 45% of the CBT group, compared to 27% receiving usual care.

{{cta_3}}

Pain Reprocessing Therapy: Retraining the Brain's Pain Response

12. 66% of PRT participants became pain-free or nearly pain-free after 4 weeks of treatment for chronic back pain

In a 151-patient back pain trial with participants averaging 10 years of symptoms, Pain Reprocessing Therapy reduced pain intensity to near-zero in two-thirds of participants. By comparison, 20% of the placebo group and 10% of the usual-care group reached the same threshold. Mean post-treatment pain scores were 1.18 (PRT) vs 2.84 (placebo) vs 3.13 (usual care) on a 0-10 scale.

13. PRT produced effect sizes of -1.14 vs placebo, a magnitude described as "very rarely observed" in chronic pain research

PRT's large effect sizes (Hedges' g = -1.14 vs placebo, -1.74 vs usual care) were substantially larger than what most behavioral interventions achieve. For context, CBT typically produces effect sizes in the 0.3-0.5 range for pain intensity. The researchers noted these results were among the largest ever reported in a chronic pain clinical trial.

14. 55% of PRT participants remained pain-free or nearly pain-free at 5-year follow-up with no booster sessions

A 5-year PRT follow-up confirmed that more than half of those who responded to treatment maintained their gains over five years. No booster sessions were provided during the follow-up period. This durability suggests that PRT may produce lasting changes in how the brain processes pain signals in adults with chronic primary back pain, rather than providing temporary symptom management.

15. PRT reduced pain-related brain activation in the anterior midcingulate cortex and anterior insula on fMRI

Neuroimaging data from the PRT trial showed that treatment reduced pain-related brain activation and strengthened connectivity between prefrontal (cognitive) and pain-processing circuits. These neural changes correlated with participants' clinical pain reduction. The findings provide a biological mechanism for how psychological treatment may alter chronic pain at the brain level.

Emotional Awareness and Expression Therapy: Addressing the Emotional Roots of Pain

16. 63% of older veterans receiving EAET achieved clinically significant pain reduction vs 17% with CBT

A 126-veteran randomized trial of adults ages 60-95 with chronic musculoskeletal pain compared EAET directly against CBT. EAET, which helps patients process suppressed emotions connected to pain, produced clinically significant pain reduction (≥30% improvement) in nearly four times as many participants as CBT. More than two-thirds of the study sample also had a psychiatric diagnosis, making these results particularly relevant for complex patients.

17. EAET pain reduction sustained at 6 months: 41% maintained gains vs 14% of CBT participants

Beyond the initial treatment period, EAET's 6-month durability showed persistent advantages over CBT. In the EAET group, 41% of participants still met the threshold for clinically significant pain reduction, compared to 14% in the CBT group. This durability is noteworthy because many behavioral interventions show declining effects after active treatment ends.

18. 22.5% of fibromyalgia patients receiving EAET achieved 50% or greater pain reduction vs 8.3% in CBT

In a trial of 230 adults with fibromyalgia, EAET produced higher pain relief rates than the current standard behavioral approach. The 50% pain-reduction threshold is a stringent benchmark rarely achieved in fibromyalgia treatment. These findings suggest that for patients with centralized pain conditions, addressing emotional processing may be more effective than cognitive restructuring alone.

ACT, Mindfulness, and Brief Interventions

19. ACT produces a medium effect on pain intensity with SMD of -0.57 at 3-month follow-up

A 2024 ACT meta-analysis of 21 randomized trials found Acceptance and Commitment Therapy reduces pain intensity with a small-to-medium effect size. ACT's approach, helping patients engage in valued activities despite pain rather than focusing on pain elimination, may be particularly effective for patients who have not responded to other behavioral pain approaches. Face-to-face delivery significantly outperformed internet-delivered ACT for physical outcomes.

20. Mindfulness-based stress reduction decreases chronic low back pain intensity by approximately 1 point on a 0-10 scale

Meta-analytic evidence confirms that MBSR reduces low back pain with an effect size of SMD = -0.48 compared to usual care. While a 1-point change may seem modest, this reduction crosses the threshold for minimum clinically important difference on the Numerical Rating Scale. MBSR also produces improvements in depression, anxiety, and functional limitation.

21. A single-session pain skills class matched 8-session CBT for reducing pain catastrophizing

Empowered Relief, a 2-hour pain management skills session, proved non-inferior to 8-session CBT for reducing pain catastrophizing in 263 adults with chronic low back pain. Pain catastrophizing scores dropped 9.12 points (single session) vs 10.94 points (8 sessions). Six-month follow-up data showed benefits for pain bothersomeness and anxiety continued to improve, suggesting that brief targeted interventions may serve as viable access points for the underserved chronic pain population.

Exercise, Movement, and Complementary Modalities

22. Exercise reduces chronic low back pain by 15.2 points on a 100-point scale, supported by 249 randomized trials

The largest Cochrane exercise review, encompassing 249 trials and 24,486 patients, found a mean pain reduction of 15.2 points (on a 0-100 VAS) compared to no treatment or usual care. This effect size is clinically meaningful and consistent across exercise types. Exercise also improved function and was associated with minimal adverse events.

23. Yoga reduces chronic low back pain intensity with SMD = -0.37 across 15 randomized trials

A systematic review of 27 yoga studies involving 2,702 participants found consistent reductions in chronic low back pain compared to passive controls. A 2024 trial reported women's pain scores dropped from 6.80 to 3.30 on a 10-point VAS after 8 sessions, a 51% reduction. The effect was most pronounced in studies with longer intervention periods, suggesting sustained practice may amplify benefits.

24. Biofeedback achieves moderate pain intensity reduction for chronic back pain with Hedges g = 0.60

A biofeedback pain meta-analysis of 21 studies and 1,062 patients found stable, moderate reductions in pain intensity (g = 0.60 at post-treatment, g = 0.62 at follow-up). Biofeedback also reduced depression (g = 0.40) and disability (g = 0.49). As a modality that teaches patients to regulate physiological stress responses, biofeedback complements other behavioral approaches within multimodal pain programs.

Pain Neuroscience Education and Combined Approaches

25. Pain neuroscience education combined with other interventions achieves large effects on pain intensity with SMD = -1.71

A 2024 systematic review found that when pain neuroscience education is delivered alongside exercise or physiotherapy, pain intensity reductions are substantially larger than with either approach alone. PNE helps patients understand nervous system pain signals, which may reduce fear-avoidance behavior and increase engagement with active treatments. The combined effect size of -1.71 represents a large clinical difference.

26. Multidisciplinary pain program improvements in pain and disability hold at 3-year follow-up

A 2025 long-term follow-up confirmed that the small-to-moderate improvements in pain, pain interference, and depression observed after multidisciplinary CBT-based programs persisted at both one-year and three-year assessments. Three-year follow-up data is rare in behavioral pain research, making this finding particularly valuable for clinicians discussing expected treatment trajectories with patients who have experienced short-lived relief from other interventions.

Digital, Telehealth, and Emerging Platforms

27. Coach-led telehealth CBT: 32% of participants achieved clinically significant pain reduction vs 20.8% with usual care

The largest phase 3 telehealth trial enrolled 2,331 patients with high-impact chronic musculoskeletal pain across four US health systems. At 3 months, 32.0% of those receiving coach-led telehealth CBT achieved ≥30% pain reduction, compared to 26.6% in an online self-guided group and 20.8% in usual care. Benefits were sustained through 12 months, demonstrating that coached telehealth delivery is both effective and scalable.

28. FDA-authorized VR therapy achieved 30% or greater pain reduction in 66% of users with chronic low back pain

In a 179-patient VR trial, an immersive VR-based program combining CBT principles, relaxation, and interoceptive training achieved ≥30% pain reduction in 66% of users, compared to 41% in a sham VR control. This became the first VR therapeutic authorized by the FDA for chronic pain in November 2021. Two-year follow-up data published in 2024 confirmed durability of the pain reduction.

29. Pediatric intensive pain programs produce large effect sizes of -1.28 for pain intensity at 12 months

A pediatric pain meta-analysis found that intensive interdisciplinary pain treatment for children and adolescents with chronic pain produced large improvements in pain intensity (effect size = -1.28), disability (-1.91), and missed school days (-0.99) at 12-month follow-up. These programs, which combine psychological, physical, and occupational therapy, represent a growing evidence base showing behavioral pain approaches work across the lifespan.

Cost Savings and Healthcare Utilization

30. Multidisciplinary pain programs reduce total cost of care by $754 per member per month

A health plan cost analysis of members enrolled in a multidisciplinary pain program found $754 per-member-per-month (PMPM) reductions in total cost of care and $846 PMPM reductions in medical costs (excluding pharmacy). The program also reduced diagnostic imaging by 52 per 1,000 members per month and inpatient admissions by 20 per 1,000 members per month. For health systems and payers evaluating non-pharmacologic pain programs, these per-member savings compound rapidly at scale.

How Lin Health Helps with Chronic Pain

The statistics above document what a growing body of research has established: behavioral and psychological approaches can meaningfully reduce pain intensity for adults living with chronic pain. Lin Health's program is built on these findings, applying a brain-first pain approach that addresses the nervous system patterns keeping pain signals active after tissues have healed.

The program pairs each patient with a trained recovery coach for weekly live sessions, between-session chat support, and access to an app with structured learning and practice modules. Modalities include CBT, ACT, emotional awareness and expression therapy, somatic tracking, and pain reprocessing therapy, selected based on each patient's presentation and goals.

Lin Health is covered by most major insurance plans in Colorado, Texas, Florida, California, and New York, with growing coverage in additional states. Wait times are short, with most patients receiving a same-day callback after signing up. For clinicians, Lin Health partners with health systems and providers including Mayo Clinic, WellSpan, and AdventHealth to offer a structured referral pathway for patients with chronic primary pain.

If behavioral approaches may be relevant for you or your patients, check your eligibility. Most enrolled patients pay zero out of pocket.

FAQ

How much pain reduction can evidence-based programs achieve?

Results vary by program and condition. Pain Reprocessing Therapy reduced chronic back pain to near-zero in 66% of participants. CBT and ACT typically produce small-to-moderate reductions. Exercise therapy reduces low back pain by about 15 points on a 100-point scale. Individual response depends on pain type, duration, and co-occurring conditions.

Which evidence-based program is most effective for chronic pain?

No single program is most effective for all patients. EAET outperformed CBT in trials with older veterans and fibromyalgia patients. PRT showed large effects for chronic primary back pain. CBT has the broadest evidence base across conditions. The right fit depends on pain type, patient goals, and available modalities.

How long do pain reductions from behavioral programs last?

Long-term data is encouraging. PRT participants maintained near-zero pain at 5 years without booster sessions. Multidisciplinary CBT improvements held at 3-year follow-up. MBSR and CBT benefits persisted at 1 year for chronic low back pain. Durability appears stronger when programs address the psychological and emotional drivers of pain persistence.

Are telehealth pain programs as effective as in-person treatment?

Recent evidence supports telehealth as an effective delivery method. A 2025 trial of 2,331 patients found coach-led telehealth CBT achieved clinically significant pain reduction in 32% of participants vs 20.8% usual care. Telehealth shows comparable outcomes to in-person treatment without increased emergency visits or hospitalizations.

Does insurance cover evidence-based pain programs?

Coverage varies by plan and state. The CDC's 2022 guideline recommendation for non-pharmacologic first-line treatment has accelerated insurance adoption. Programs like Lin Health are covered by major carriers in multiple states, with most enrolled patients paying zero out of pocket. Check with your insurer or program to confirm eligibility.

What is the evidence for treating chronic pain without medication?

Federal guidelines and peer-reviewed research support non-pharmacologic approaches as first-line for many chronic pain conditions. Psychological therapies are supported by 75 randomized trials. Exercise therapy is backed by 249 trials. The CDC's 2022 guideline recommends maximizing non-pharmacologic options before opioids. These approaches can work alongside, rather than replace, appropriate medical care.

This article is for informational purposes only and is not medical advice. The statistics presented reflect published research findings and may not apply to all individuals or conditions. Consult a qualified healthcare provider before making changes to your pain management plan.